Vistagen Therapeutics Q1 2026 Earnings Narrower Loss Than Expected Boosts Investor Sentiment CABO Q1 2026 Earnings EPS Beats Expectations Stock Rises Over 5 FCEL Q1 2026 Earnings EPS Surprises to the Upside Shares Dip Despite Narrowing Losses PDD Q4 2025 Earnings EPS Misses Estimates Amid Competitive Pressures MTEX Q3 2023 Earnings Narrow Profit Reported Amidst Challenging Environment CLIR Q1 2026 Earnings EPS Misses Estimates as Company Navigates Development Stage